404
+1-313-307-4176
We are working from home under lockdown. Our team is continuously tracking the impact of COVID-19 across different industries and we will incorporate those insights in our reports. For any specific query, mail us at [email protected]
Protein Engineering Market | Covid-19 Impact Analysis
The Protein Engineering Market is Segmented by Products & Services Type (Instruments, Consumables, and Software & Services), by Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Others), by Technology Type (Rational Protein Design, Irrational Protein Design), by End-User Type (Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)
Covid-19 has impacted the market dynamics, competition, and global supply chains. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
Protein Engineering market is likely to witness a CAGR of 12.6% during the forecast period. Increasing investments in synthetic biology and mounting focus on protein-based drug development by biotechnology and pharmaceutical companies are the major factors that are driving the protein engineering market.
|
Protein Engineering Market - Snapshot |
|
|
Growth |
12.6% for the next five years |
|
Major Products & Services |
Instrument Type |
|
Major Protein Type |
Monoclonal Antibodies |
|
Region with the highest demand |
North America |
|
Key Players |
Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Agilent Technologies, Inc., Waters Corporation, Danaher Corporation, Codexis, Inc., New England Biolabs, Inc., PerkinElmer, Innovagen AB, GE Healthcare, CUSABIO TECHNOLOGY LLC, Promega Corporation, Merck KGaA, GenScript Biotech Corporation, Takara Bio, Inc., Enantis S.R.O., InvivoGen, Pace Analytical, Aspira Chemical, Zymeworks, Inc., Abzena, Ltd., PhyNexus, Inc., ProteoGenix, and Creative Biolabs. |
Wish to Get a Free Sample? Register Here
Based on the products & services type, the market is segmented as instruments, consumables, and software & services. The instrument segment held the largest share of the market in 2019, and is expected to remain dominant during the forecast period. Technological advancements and the high price of mass spectroscopy and crystallography instruments are the major factors leading to dominance of the instrument segment.
Based on the protein type, the market is segmented as monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and others. The monoclonal antibodies segment dominated the market in 2019, and is expected to maintain its position during the forecast period. Increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases is the major factor behind its dominance.
In terms of regions, North America is estimated to be the largest market during the forecast period. Presence of well-established CROs, increasing investment towards R&D, and the availability of the latest techniques and instruments for drug discovery research are the major factors behind the dominance of the North American market.
Know which region offers best growth opportunities. Register Here
Asia-Pacific is expected to be the fastest-growing market during the forecast period. Advancements in genomics and proteomics research and government initiatives and funding for protein-based drug research in key countries are the major factors behind the extra-ordinary growth of the region’s market.
Protein engineering is the process of altering a protein sequence to attain a desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity. Protein engineering can be categorized by protein type into monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and others. On the basis of products & services the market can be categorized into instruments, consumables, and software & services. On the basis of technology type, the market can be categorized into rational protein design and irrational protein design. Major end-user in the market are biopharmaceutical companies, contract research organizations, and academic research institutes.
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
|
Protein Engineering Market Research Report - Features |
|
|
Market Segmentation |
5 |
|
Regions Covered |
4 |
|
Countries/Sub-Regions Covered |
15 |
|
No. of Figures & Tables |
>120 |
|
Company Profiles |
10 |
The protein engineering market is segmented into the following categories.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Market Segmentation
Competitive Benchmarking
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The protein engineering market is expected to witness an impressive growth of 12.6% CAGR in the foreseeable future.
North America is expected to be the largest protein engineering market during the next five years.
The monoclonal antibodies segment is expected to remain dominant in the protein engineering market in the coming years.
Some of the major factors driving the protein engineering market are Increasing investments in synthetic biology and mounting focus on protein-based drug development by biotechnology and pharmaceutical companies.
Why are We Class Apart?
Advanced Materials Offer Next Growth Wave
We Specialize in Composites & other Materials Market Research
>60% of the First Buyers Come Back to Us
>95% Client Satisfaction Ratio, the Industry's Highest
Clients Across the Value Chain
Track the Latest Trends in Advanced Materials
Know High Growth Opportunities
WE ACCEPT
